AXA Group Q3 2024 Earnings Call Highlights

In the latest earnings call, AXA Group CEO Thomas Buberl presented a robust financial report for the first nine months of 2024, showcasing a 7% increase in total revenues across its various business lines. The company's Property & Casualty (P&C), as well as Life & Health sectors, both experienced a 7% rise in revenue, with disciplined pricing and improved customer retention contributing to this growth. AXA also maintained a strong capital position with a Solvency II ratio of 221% and expects an underlying earnings per share (EPS) growth of 6% to 8% for the year, aligning with its three-year plan.

Key Takeaways

• AXA's total revenues increased by 7%, with equal growth in both P&C and Life & Health sectors.
• The company's Solvency II ratio stands strong at 221%.
• An anticipated underlying EPS growth of 6% to 8% is in line with AXA's three-year plan.
• AXA observed disciplined pricing and improved customer retention, especially in commercial lines.
• Life premiums rose by 7%, bolstered by strong sales in Japan and Italy.
• Net flows year-to-date reached €0.9 billion, a significant rebound from the previous year's negative flows.
• AXA expects to achieve a 200 basis point improvement in the P&C combined ratio.
• Growth in Health premiums was notable outside Europe, with significant increases in Mexico and Turkey.

Company Outlook

• AXA anticipates continued underlying EPS growth within the 6% to 8% target range for 2024.
• The company expects to hit the upper end of its capital generation guidance of 25 to 30 points.
• A return to profitability for the UK Health segment is projected by 2025.

Bearish Highlights

• A 50 basis point decrease in NBV margin was reported, mainly due to business mix and financial assumptions.
• Net outflows of €600 million in Unit-Linked products are a concern.
• In France, sales increased significantly but with slightly lower margins.

Bullish Highlights

• Strong Health premium growth was seen in Mexico and Turkey, with a 15% increase in Mexico and a near doubling in Turkey.
• The company is confident in achieving its growth target for P&C, estimating 4-5% growth in 2025.
• Pricing in casualty is accelerating in the U.S., with property prices increasing by 7-8%.

Misses

• Despite overall growth, higher-margin sales in Switzerland and Japan declined.
• The second half of the year typically sees lower performance in capital generation.

Q&A Highlights

• AXA expects a €100 million impact from a 25 basis point decrease in discount rates if interest rates remain stable.
• The company is increasing internal reinsurance in its P&C business to optimize capital.
• Biannual valuation exercises for casualty reserves have not revealed any issues.
• Claims from hurricanes Helene and Milton are estimated at €200 million.
• AXA does not engage in life and health reinsurance, focusing solely on P&C.
• Discussions about potential integration with Monte dei Paschi could occur after the joint venture agreement expires in 2027.
• AXA IM experienced lower third-party net inflows but retained all clients despite the upcoming sale of the asset management unit.

InvestingPro Insights

AXA's strong financial performance, as reported in the recent earnings call, is further supported by data from InvestingPro. The company's market capitalization stands at an impressive $78.7 billion, reflecting its significant presence in the insurance industry.

One of the key InvestingPro Tips highlights that AXA has maintained dividend payments for 45 consecutive years, underscoring its commitment to shareholder returns and financial stability. This aligns well with the company’s reported strong Solvency II ratio of 221% and its anticipated underlying EPS growth of 6% to 8%.

The company’s P/E ratio of 10.6 suggests that AXA's stock may be undervalued relative to its earnings potential. This is particularly interesting given another InvestingPro Tip indicating that AXA is trading at a low P/E ratio relative to its near-term earnings growth. This could be an attractive point for investors, especially considering the company's projected growth and strong market position.

AXA's revenue for the last twelve months as of Q2 2024 reached $97 billion, with a growth rate of 6.25%. This aligns with the 7% increase in total revenues reported in the earnings call, demonstrating consistent growth across different reporting periods.

It's worth noting that InvestingPro offers 8 additional tips for AXA, providing even more comprehensive insights for investors looking to deepen their understanding of the company's financial health and market position.

While the earnings call highlighted strong performance in various sectors, an InvestingPro Tip cautions that AXA suffers from weak gross profit margins. This is reflected in the gross profit margin of 15.1% for the last twelve months as of Q2 2024. However, this should be considered in the context of the insurance industry's typical margin structures.

Overall, the InvestingPro data and tips complement the earnings call information, providing a more rounded view of AXA's financial position and market performance. These insights reinforce the company's strong market presence and potential for continued growth, while also highlighting areas that investors may want to monitor closely.

Conclusion

AXA (ticker: AXA), under the leadership of Group CEO Thomas Buberl, has demonstrated a consistent and disciplined approach to growth, as reflected in the latest earnings call. Despite some challenges, AXA remains confident in its ability to meet its long-term targets and maintain its position as a leading global insurer.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.